Number of the records: 1  

Current and Novel Inhibitors of HIV Protease

  1. 1.
    SYSNO ASEP0336551
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleCurrent and Novel Inhibitors of HIV Protease
    Author(s) Pokorná, Jana (UOCHB-X) RID
    Machala, L. (CZ)
    Řezáčová, Pavlína (UOCHB-X) RID, ORCID
    Konvalinka, Jan (UOCHB-X) RID, ORCID
    Number of authors4
    Source TitleViruses. - : MDPI
    Roč. 1, č. 3 (2009), s. 1209-1239
    Number of pages31 s.
    Languageeng - English
    CountryCH - Switzerland
    KeywordsHIV protease ; protease inhibitor ; HAART
    Subject RIVCE - Biochemistry
    R&D Projects1M0508 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    CEZAV0Z40550506 - UOCHB-X (2005-2011)
    UT WOS000280413200044
    DOI10.3390/v1031209
    AnnotationThis review describes all nine currently available FDA-approved protease inhibitors, discusses their pharmacokinetic properties, off-target activities, side-effects, and resistance profiles. The compounds in the various stages of clinical development are also introduced, as well as alternative approaches, aiming at other functional domains of HIV PR. The potential of these novel compounds to open new way to the rational drug design of human viruses is critically assessed.
    WorkplaceInstitute of Organic Chemistry and Biochemistry
    Contactasep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Viktorie Chládková, Tel.: 232 002 434
    Year of Publishing2011
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.